The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 23, 2021
Filed:
Jan. 27, 2020
Applicants:
Cumberland Pharmaceuticals Inc., Nashville, TN (US);
Vanderbilt University, Nashville, TN (US);
Inventors:
Leo Pavliv, Cary, NC (US);
Bryan Voss, Nashville, TN (US);
James West, Nashville, TN (US);
Erica Carrier, Nashville, TN (US);
Assignees:
Cumberland Pharmaceuticals, Inc., Nashville, TN (US);
Vanderbilt University, Nashville, TN (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 31/421 (2006.01); A61K 31/422 (2006.01); C07D 263/30 (2006.01); C07D 407/04 (2006.01); C07D 413/04 (2006.01); C07D 493/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/421 (2013.01); A61K 9/00 (2013.01); A61K 9/0019 (2013.01); A61K 9/2059 (2013.01); A61K 9/4858 (2013.01); A61K 31/422 (2013.01); C07D 263/30 (2013.01); C07D 407/04 (2013.01); C07D 413/04 (2013.01); C07D 493/08 (2013.01);
Abstract
The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.